Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The genome polyprotein of Hepatitis C virus (HCV) genotype 1b is a large precursor protein encoded by the viral RNA genome. It is approximately 3,011 amino acids long and contains all mature structural and nonstructural proteins necessary for the viral life cycle. The polyprotein undergoes co- and post-translational cleavage by host and viral proteases into structural proteins (Core, E1, E2) and nonstructural proteins (NS2, NS3, NS4A, NS4B, NS5A, NS5B). These individual proteins are essential for virion assembly, replication complex formation, and modulation of host responses. Genotype 1b infections are associated with more severe disease progression and treatment challenges compared with other genotypes.
Varies depending on the specific drug. DAAs directly inhibit viral proteins essential for replication. Interferon stimulates the immune system.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genome Polyprotein (Hepatitis C Virus Genotype 1b) (HCV 1b Polyprotein).